| Literature DB >> 27488750 |
Paulina Wejner-Mik1, Maria Sobczak1, Dawid Miskowiec2, Katarzyna Wdowiak-Okrojek1, Jaroslaw D Kasprzak1, Piotr Lipiec1.
Abstract
OBJECTIVE: Despite premedication, anxiety in patients undergoing transesophageal echocardiography (TEE) is prevalent, often causing adverse physiological and psychological effects and contributing to decreased patient compliance. We aimed to evaluate the feasibility of cognitive-behavioral intervention (CBI) in patients undergoing TEE and to assess its impact on the severity of anxiety, patient's and physician's comfort, and administered dose of sedatives.Entities:
Mesh:
Substances:
Year: 2015 PMID: 27488750 PMCID: PMC5331353 DOI: 10.5152/AnatolJCardiol.2015.6514
Source DB: PubMed Journal: Anatol J Cardiol ISSN: 2149-2263 Impact factor: 1.596
Patients’ demographic characteristics
| Variable | Overall (n=49) | Intervention Group (n=26) | Control group (n=23) | |
|---|---|---|---|---|
| Age, years | 66 (58–70) | 67 (57–70) | 66 (59–68) | 0.718[ |
| Male, n (%) | 27 (55) | 15 (58) | 12 (52) | 0.698[ |
| Weight, kg | 75 (71–89) | 75 (71–90) | 76 (70–86) | 0.732[ |
| Height, cm | 169 (163–175) | 166 (162–175) | 170 (164–175) | 0.954[ |
| BMI, kg/m2 | 26.4 (24.6–31.0) | 27.4 (24.6–31.2) | 26.2 (24.4–29.4) | 0.545[ |
| EF, % | 55 (45–60) | 55 (38–59) | 52 (46–60) | 0.509[ |
BMI - body mass index; EF - left ventricular ejection fraction
Mann–Whitney U test;
Pearson’s chi-square test
Indications for transesophageal echocardiography
| Indication | Intervention group (n=26) | Control group (n=23) |
|---|---|---|
| Atrial fibrillation, n (%) | 13 (50) | 11 (48) |
| Congenital defect, n (%) | 5 (19) | 6 (26) |
| Valvular disease, n (%) | 4 (15) | 3 (13) |
| Infective endocarditis, n (%) | 4 (15) | 2 (9) |
| Intracardiac mass, n (%) | 0 (0) | 1 (4) |
Values of assessed end-points in the studied groups
| Variable | Intervention group (n=26) | Control group (n=23) | |
|---|---|---|---|
| Mean level of pre-TEE well-being[ | 64.81±16.15 | 55.0±12.25 | 0.022[ |
| Mean level of patients’ comfort during TEE | 1.27±0.45 | 1.83±0.65 | <0.001[ |
| Good tolerance, n (%) | 19 (73) | 7 (30) | 0.006[ |
| Moderate tolerance, n (%) | 7 (27) | 13 (57) | |
| Bad tolerance, n (%) | 0 (0) | 3 (13) | |
| Mean level of echocardiographer’s comfort during TEE* | 1.19±0.40 | 1.78±0.60 | <0.001[ |
| High level of comfort, n (%) | 21 (81) | 7 (30) | 0.001[ |
| Moderate level of comfort, n (%) | 5 (19) | 14 (61) | |
| Low level of comfort, n (%) | 0 (0) | 2 (9) | |
| Midazolam administration, n (%) | 8 (31) | 21 (91) | <0.001[ |
| Mean midazolam administered dose, mg | 1.6±0.5 | 2.7±1.6 | 0.009[ |
| Mean indexed midazolam administered dose, µg/kg | 17.9 (11.0–26.2) | 27.8 (25.0–33.3) | 0.011[ |
| Successful Valsalva maneuver, n (%) | 3/4 (75%) | 3/6 (50%) | 0.571[ |
TEE – transesophageal echocardiography
- scale from 0 to 100: 0–lowest imaginable level of well-being, highest imaginable anxiety, 100-highest imaginable level of well-being, lowest imaginable anxiety
- three degree scale: 1–good tolerance/comfort, 2–moderate tolerance/comfort, 3–bad tolerance/comfort of examination
Student’s-t test for independent variables;
Pearson’s chi-square test;
Mann–Whitney U test;
Fisher exact test